dc.creatorJorge P.A.R.
dc.creatorDe Almeida E.A.
dc.creatorOzaki M.R.
dc.creatorJorge M.
dc.creatorCarneiro A.
dc.date2005
dc.date2015-06-26T14:09:21Z
dc.date2015-11-26T14:09:22Z
dc.date2015-06-26T14:09:21Z
dc.date2015-11-26T14:09:22Z
dc.date.accessioned2018-03-28T21:09:55Z
dc.date.available2018-03-28T21:09:55Z
dc.identifier
dc.identifierArquivos Brasileiros De Cardiologia. , v. 84, n. 4, p. 314 - 319, 2005.
dc.identifier0066782X
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-18844440664&partnerID=40&md5=d87ccdca05015f5c869fb86f0c2fdd41
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/93771
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/93771
dc.identifier2-s2.0-18844440664
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1241217
dc.descriptionObjective: To compare the effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, aortic atherosclerosis, and the content of malondialdehyde (MDA) in native and oxidized LDL and in the arterial wall of hypercholesterolemic rabbits after adjusting the dosages of those statins to reduce total serum cholesterol levels to similar values. Methods: Male rabbits were divided into the following 6 groups of 10 animals (n=10): 1) GH (control) - hypercholesterolemic animals; 2) GA - atorvastatin; 3) GF - fluvastatin; 4) GP - pravastatin; 5) GS - simvastatin; and 6) GN - normal. The animals were fed a standard food preparation enriched with 0.5% cholesterol and 2% coconut oil for 45 days. Fifteen days after beginning the experiment, atorvastatin, fluvastatin, pravastatin and simvastatin were administered for 15 days through gavage, and the dosages were adjusted to obtain similar cholesterol values in each group. At the end of the experiment, a blood sample was withdrawn for determining total cholesterol and separating the lipoproteins, and a segment of the thoracic aorta was removed to be used for studying endothelial function and lipid peroxidation, and for measuring aortic atherosclerosis in histological sections. Results: The statins significantly reduced total serum cholesterol levels, LDL-cholesterol levels, and aortic atherosclerosis. The MDA content was also significantly reduced in native and oxidized LDL, as well as in the arterial wall. Endothelium-dependent relaxation was significantly greater in the treated group compared with that in the hypercholesterolemic group. Conclusion: The statins, at dosages adjusted, had a significant and similar effect in reducing lipid peroxidation in native and oxidized LDL-C and in arterial walls, in decreasing aortic atherosclerosis, and in reverting endothelial dysfunction.
dc.description84
dc.description4
dc.description314
dc.description319
dc.descriptionShepherd, J., Cobbe, S.M., Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West Scotland Coronary Prevention Study (WOSCOPS) (1995) N Engl J Med, 333, pp. 1301-1307
dc.descriptionDomws, J.R., Clearfield, M., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels (1998) N Engl J Med, 339, pp. 1349-1357
dc.description(1998) N Engl J Med, 339, pp. 1349-1357
dc.descriptionRandomized trial of cholesterol lowering in 4,444 patients with coronary heart disease (1994) Lancet, 344, pp. 1383-1389
dc.descriptionSacks, F.M., Pfeffer, M.A., The effect of pravastatin on coronary events after myocardial infaction in patients with average cholesterol levels. Care Study (1966) N Engl J Med, 14, pp. 1001-1009
dc.descriptionMRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals: A randomized placebo-controlled trial (2002) Lancet, 360, pp. 23-33
dc.descriptionVaughan, C.J., Gotto, A.M., Basson, C.T., The envolving role of statins in the management of atherosclerosis (2000) J Am Coll Cardiol, 35, pp. 1-10
dc.descriptionRicker, P.M., Rifail, N., Lowenthal, S.P., Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hyperchoelsterolemia (2001) Circulation, 103, pp. 1191-1193
dc.descriptionBellosta, S., Bernini, F., Ferri, N., Quarato, P., Canavesi, M., Arnaboldi, L., Direct vascular effects of HMGCoA reductase inhibitors (1998) Atherosclerosis, 137, pp. S101-S109
dc.descriptionScalia, R., Appel, J.Z., Lefer, A.M., Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit (1998) Arterioscl Thromb Vasc Biol, 18, pp. 1093-1100
dc.descriptionDangas, G.J., Badimon, L., Smith, D.A., Levine, A., Ambrose, J.A., Pravastatin therapy in hyperlipidemia. Effects on thrombus formation and the systemic hemostatic profile (1999) Am Coll Cardiol, 33, pp. 1294-1304
dc.descriptionLefer, A.M., Scalia, R., Lefer, D.J., Vascular effects of HMG-COA reductase inhibitors unrelated to cholesterol lowering: New concepts for cardiovascular disease (2001) Cardiovasc Res, 49, pp. 281-287
dc.descriptionWilliams, D., Feely, J., Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors (2002) Clin Pharmacokinet, 41, pp. 343-370
dc.descriptionCorsini, A., Maggi, F., Catapano, A.L., Pharmacology of competitive inhibitors of HMGCoA reductase (1995) Pharmacological Res, 31, pp. 9-27
dc.descriptionDansette, P.M., Joen, M., Rons, C., HMGCoA reductase activity in human liver microssomes: Comparative inhibition by statins (2000) Exp Tox Pathol, 52, pp. 145-148
dc.descriptionJones, P., Kafonek, S., Laurora, I., Hunninghake, Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia. (The Curves Study) (1998) Am J Cardiol, 81, pp. 582-587
dc.descriptionRibeiro, J.P.A., Ozaki, M.K., Effects of simvastatin and pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits (1994) Exp Toxic Pathol, 46, pp. 465-469
dc.descriptionRibeiro, J.P.A., Eros, A.A., Ozaki, M.R., Rapid reversal of endothelial dysfunction in hypercholeterolemic rabbits treated with sinvastatin and pravastatin (1997) Clin Exp Pharmacol Physiol, 24, pp. 948-995
dc.descriptionCassini, A.F., Ferrali, M., Pompella, A., Maellaro, E., Comporti, M., Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene-intoxicated mice (1986) Am J Pathol, 123, pp. 520-531
dc.descriptionHavel, R.J., Eder, H.A., Bragdon, J.H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum (1955) J Clin Invest, 34, pp. 1345-1353
dc.descriptionLowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.L., Protein measurement with the Folin phenol reagent (1951) J Biol Chem, 193, pp. 265-275
dc.descriptionParthasarathy, S., Khoo, J.C., Miller, E., Barnett, J., Witztum, J., Steinberg, D.E., Low density lipoprotein rich in oleic acid is preotected against oxidative modifications: Implications for dietary prevention of atherosclerosis (1990) Porc Natl Acad Sci USA, 87, pp. 3894-3898
dc.descriptionBuege, J.A., Aust, S.D., Microsomal lipid peroxidation (1978) Methods Enzymol, 52, pp. 302-310
dc.descriptionLehr, H.A., Mankoff, D.A., Corwin, D., Application of Photoshop-based analysis to quantification of hormone receptor expression in breast cancer (1997) J Histochem Cytochem, 45, pp. 1559-1565
dc.descriptionLehr, H.A., Van Der Loos, C.M., Teeling, P., Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis (1999) J Histochem Cytochem, 47, pp. 119-126
dc.descriptionFleiss, J.L., (1981) Statistical Methods for Rates and Proportions, , New York: John Wiley, 2nd ed
dc.descriptionMilliken, G.A., Johnson, D.E., (1984) Analysis of Messy Data. Vol I: Designed Experiments, 1. , New York: Van Nostrand Reinhold
dc.descriptionMotti, C., Gnasso, A., Cortese, C., Statins: Similarities and differences in the pharmacological, clinical and laboratory aspects (2000) Ann Ital Med Int, 15, pp. 96-102
dc.descriptionCorsini, A., Maggi, F.M., Catapano, A.L., Pharmacology of competitive inhibitors of HMG-CoA reductase (1995) Pharmacol Res, 31, pp. 9-27
dc.descriptionNegre-Aminou, P., Van Erck, M., Van Leeuwen, R.E., Collard, J.G., Cohen, L.H., Differencial effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells (2002) Biochm Pharmacol, 61, pp. 991-998
dc.descriptionDavignon, J., Mabile, L., Mechanisms of action of statins and their pleiotropic effects (2001) Ann Endocrinol, 62, pp. 101-102. , Paris
dc.descriptionKoh, K.K., Effects of statins on vascular wall: Vasomotor function, inflammation and plaque stability (2000) Cardiovasc Res, 47, pp. 648-657
dc.descriptionTakemoto, M., Lia, J.K., Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (2001) Arterioscler Thrombo Vasc Biol, 21, pp. 1712-1719
dc.descriptionHughes, A.D., The role of isoprenoids in vascular smooth muscle: Potential benefits of statins unrelated to cholesterol lowering (1996) J Hum Hypertens, 10, pp. 387-390
dc.descriptionCarneado, J., Alvarez De Sotomayor, M., Perez-Guerrero, C., Simvastatin improves endothelial function in spontaneiusly hypertensive rats through a superoxide dismutase mediated antioxidant effect (2002) J Hypertens, 20, pp. 429-437
dc.descriptionSuzumura, K., Tanaka, K., Yasuhara, M., Narita, H., Inhibitory effects of fluvastastin and its metabolites on hydrogen peroxide induced oxidative destruction of hemin and low desnsity lipoprotein (2000) Biol Pharmacol Bull, 23, pp. 837-878
dc.descriptionSalonen, R., Nyyssonen, K., Porkkala-Sarataho, The Kuopio Atherosclerosis Prevention Study: Effects of pravastatin teatment on lipids, oxidation resistance of lipoproteins and atherosclerosis progression (1995) Am J Cardiol, 76, p. 3
dc.descriptionWassmann, S., Laufs, U., Muller, K., Cellular antioxidant effects of atorvastatin in vitro and in vivo (2002) Arterioscler Thromb Vasc Biol, 22, pp. 300-305
dc.descriptionLaufs, V., Fata Vita, B.A., Plutzky, J., Liao, K., Up regulation of endothelial nitric oxide after lipid lowering therapy in hypercholesterolemic patients (1998) Circulation, 98, pp. 211-216
dc.descriptionPentikainen, P.J., Saraheimo, M., Swartz, J.I., Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans (1992) L Clin Pharmacol, 32, pp. 136-140
dc.descriptionGermershausern, J.I., Hunt, V.M., Bostedor, R.G., Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo (1989) Biochem Biophys Res Comm, 158, pp. 667-675
dc.descriptionEndo, A., Tsujita, Y., Kuroda, M., Tanzaka, K., Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals (1979) Biochem Biophys Acta, 576, pp. 266-276
dc.descriptionThiery, J., Nebendhal, K., Walli, A.K., Effects of three different HMGCoA reductase inhibitors on hypercholesterolemia and atherosclerosis in cholesterol fed-rabbits (1991) Arterioscler Tromb, 11, p. 148
dc.descriptionDeVries, A.C., Vermeer, M.A., Bloemendal, H., Coehn, L.H., Pravastatin and simvastatin differently inhibit cholesterol biossynthesis humanas lens (1993) Invest Ophthalmol Vis Sci, 34, pp. 377-384
dc.descriptionTesfamariam, B., Frohlich, B.H., Gregg, R.E., Differencial effects of pravastatin, simvastatin, and atorvastatin on Ca++ release and vascular reactivity (1999) J Cardiovasc Pharmacol, 34, pp. 95-101
dc.descriptionJoukhadar, C., Klein, N., Schrolnberger, C., Vukovich, T., Wolzt, M., Dorner, G.T., Similar effects of atorvastatin, simvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia (2001) Thromb Haemost, 85, pp. 47-51
dc.descriptionArmstrong, M.L., Regression of coronary atheromatosis in rhesus monkeys (1975) Circ Res, 36, p. 256
dc.descriptionVesselinovith, D., Reversal of advanced atherosclerosis in reshus monkeys. Light microscopic studies (1976) Atherosclerosis, 23, p. 155
dc.descriptionDavid, A.S., Regression of advanced atherosclerosis in swine (1976) Arch Pathol Lab Med, 100, p. 372
dc.descriptionHelf, G., Worthley, S.G., Fuster, V., Fayad, Z.A., Zaman, A.G., Corti, R., Fallon, J.T., Badimon, J.J., Progression and regression of atherosclerotic lesions: Monitoring with serial noninvasive magnetic resonance imaging (2002) Circulation, 105, pp. 993-998
dc.descriptionMoreno, P.R., Lodder, R.A., Purusshothaman, K.R., Charash, W.E., Oconnor, W.N., Muller, J.E., Detection of lipid pool,thin fibrous cap,and inflamatory cells in human aortic atherosclerotic plaque by near-infrared spectroscpiy (2002) Circulation, 105, pp. 923-927
dc.descriptionVan De Pooll, S.W., Delsin, D.J., Jukema, J.W., Raman spectroscopic investigation of atorvastatin, amlodipine, on atherosclerotic plaque development in ApoE3 Leiden transgenic mice (2000) Atherosclerosis, 164, pp. 65-71
dc.descriptionNissen, S.E., Tuzcu, E.M., Soenhagen, P., Effects of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial (2004) JAMA, 291, pp. 1071-1080
dc.descriptionCannon, P.C., Braunwald, E., McCabe, C.H., Comparison of intensive and moderate lipid lowering with statins after acute coronary syndroms (2004) N Engl J Med, 350, p. 15
dc.descriptionMitoni, H., Egashira, K., Kimura, M., Fluvastatin has cholesterol-lowering independent "direct effects" on atherosclerotic vessels in high cholesterol diet-fed rabbits (2003) Pharmacol Res, 48, pp. 417-427
dc.descriptionJorge, P.A.R., Endotélio, lípides e aterosclerose (1997) Arq Bras Cardiol, 68, pp. 129-134
dc.languagept
dc.publisher
dc.relationArquivos Brasileiros de Cardiologia
dc.rightsaberto
dc.sourceScopus
dc.titleEffects Of Atorvastatin, Fluvastatin, Pravastatin, And Simvastatin On Endothelial Function, Lipid Peroxidation, And Aortic Atherosclerosis In Hypercholesterolemic Rabbits [efeitos Da Atorvastatina, Fluvastatina, Pravastatina E Simvastatina Sobre A Função Endotelial, A Peroxidação Lipídica E A Aterosclerose Aórtica Em Coelhos Hipercolesterolêmicos]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución